The pending loss of 113 centers, or 20% of Paysign’s plasma centers, is expected to weigh on future growth, DA Davidson analyst Peter Heckmann said in a note. He lowered his forecasts for 2027 and 2028, estimating the centers would have generated about $10 million to $11 million in revenue in 2027.

Paysign will continue processing payments for the customer at a number of other centers under an existing agreement, the company said. The share decline came despite Paysign reporting fourth-quarter growth in both revenue and profit. The company reiterated its full-year revenue guidance of $114 million to $117 million.